Researchers at Yale University published research in Molecular Biology and Evolution describing a new molecular analysis approach to quantify DNA changes that contribute to cancer growth.
Shares of Denmark-based Genmab climbed after the company announced a broad oncology alliance with AbbVie that is valued at close to $4 billion, one of the largest oncology partnerships in the industry.
Roche and Innovent Biologics announced a strategic R&D collaboration to discover and develop bispecific antibodies and multiple cell therapies for the treatment of hematological and solid cancers.
Zymeworks and GSK Enter Second Strategic Collaboration to Develop and Commercialize Bi-Specific Antibodies VANCOUVER, British Columbia–(BUSINESS WIRE)–Zymeworks Inc., a leader in the development of bi-specific and multi-specific antibodies and […]
VANCOUVER, British Columbia–(BUSINESS WIRE)–Zymeworks Inc. today announced that it has entered into a collaboration and license agreement with GlaxoSmithKline (GSK) for the research, development, and commercialization of novel Fc-engineered monoclonal […]
